ReviewEuropean journal of sport science2024
Is your system fit for purpose? Female athlete health considerations for rugby injury and illness surveillance systems.
Review in European journal of sport science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Article
- Performance and Wellbeing Research Priorities in Premiership Women's Rugby: A Delphi Study Including Players and Staff.European journal of sport science · 2026Article
- Beyond comfort: why breast support and protection belong in women's sport injury prevention.Frontiers in sports and active living · 2026Article
- Orchard Sports Injury and Illness Classification System (OSIICS) version 16: Updated female athlete codes and Italian and Spanish translations.JSAMS plus · 2025Article
- Breast-Related Issues in Community-Based Women's Rugby Union.European journal of sport science · 2025Article
- Up for the tackle? The pelvic floor and rugby. A review.European journal of sport science · 2024Review
- Women's rugby as a catalyst for advancing female-specific science and safety in sport.European journal of sport science · 2024Article
- Prioritise safety, optimise success! Return to rugby postpartum.European journal of sport science · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This review discusses female-specific health considerations in injury and illness surveillance and provides rugby-specific recommendations for future surveillance. Identifying priority injury and illness problems by determining those problems with the highest rates within women's rugby may highlight different priorities than sex comparisons between men's and women's rugby. Whilst sports exposure is the primary risk for health problems in sports injury and illness surveillance, female athletes have health domains that should also be considered. Alongside female athlete health domains, studies investigating rugby injuries and illnesses highlight the need to broaden the health problem definition typically used in rugby injury and illness surveillance. Using a non-time-loss health problem definition, recording female-specific population characteristics, embedding female athlete health domains and having up-to-date injury and illness coding systems should be prioritized within surveillance systems to begin to shed light on potential interactions between sports exposure, health domains and, injuries and illnesses. We call for a collaborative approach across women's rugby to facilitate large injury and illness datasets to be generated and enable granular level categorization and analysis, which may be necessary for certain female athlete health domains. Applying these recommendations will ensure injury and illness surveillance systems improve risk identification and better inform injury and illness prevention strategies in women's rugby.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.